A look at the LC and LC–MS methods that are helping to overcome challenges in sample analysis, and how this can make adeno‑associated virus (AAV)–based gene therapy more accessible.
Ximo Zhang
Advertisement
Ximo Zhang is a Senior Scientist at Waters Corporation in Milford, Massachusetts, USA.
Articles by Ximo Zhang
Recombinant adeno-associated viral therapy (rAAV) products are particularly complex. Are liquid chromatography and LC–MS the right tools for their characterization?
Advertisement
Latest Updated Articles
Applying Liquid Chromatography (LC) and Liquid Chromatography–Mass Spectrometry (LC–MS) Methods to the Characterization and Analysis of rAAVPublished: December 1st 2020 | Updated:
Applying LC and LC–MS Methods to the Characterization and Analysis of rAAVPublished: December 1st 2020 | Updated:
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
